Digital pathology solutions provide virtual and secure storage options with multi-tenant access to digital data. The cloud technology is further boosting the market for distance consultations between physicians and pathologists, globally. As this technology is leveraging the seamless integration of tools, it allows effective information exchange without the need for physical transportation of data.
The global market is highly competitive and fragmented. The increasing number of tele-consultations, the need for integrated healthcare facilities & applications in drug discovery and the companion diagnostics are driving the market growth. However, stringent regulatory concerns for primary diagnosis and the lack of standard guidelines for digital pathology are restraining the market.
The global market is segmented based on product, type, end-user and geography. The product segment includes scanner, software, communication system, and storage system and the type segment includes human and animal pathology. The end-user segment includes pharmaceutical, biotechnology companies & CRO’s, hospital & reference laboratories and academic & government research institutes. The application segment includes tele-consultation, disease diagnosis, drug discovery and education & training. Further, based on geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa and Latin America.
The major companies discussed in this report are:
Leica Biosystems Nussloch GmbH
Ventana Medical Systems, Inc
Hamamatsu Photonics K.K
Apollo Enterprise Imaging Corp.
Market analysis, with region-specific assessments and competition analysis on a global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, growing prospective opportunities, and identification of key companies that can influence the market.
Extensively researched competitive landscape section with profiles of major companies, along with their market share.
Identification and analysis of the macro and micro factors that affect the market on both, global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-range of knowledge and insights about the major players in the industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions where the industry is growing, and identify the regions that are still untapped.
1.1 Market Definition
1.2 Research Methodology
2. Executive Summary
3. Key Inferences
4. Market Overview
4.1 Current Market Scenario
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Consumers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products & Services
4.2.5 Competitive Rivalry within the Industry
5. Drivers, Restraints, Opportunities & Challenges Analysis (DROC)
5.1 Market Drivers
5.1.1 Increasing Number of Tele-Consultations
5.1.2 Rising Need for Integrated Healthcare Facilities
5.1.3 Increasing Applications in Drug Discovery and Companion Diagnostics
5.2 Market Restraints
5.2.1 Stringent Regulatory Concerns for Primary Diagnosis
5.2.2 Lack of Standard Guidelines for Digital Pathology
5.3 Market Opportunities
5.4 Key Challenges
6. Market Segmentation
6.1 By Product
6.1.3 Communication System
6.1.4 Storage System
6.2 By Type
6.2.1 Human Pathology
6.2.2 Animal Pathology
6.3 By End-User
6.3.1 Pharmaceutical, Biotechnology Companies & CRO’s
6.3.2 Hospital and Reference Laboratories
6.3.3 Academic and Government Research Institute.
6.4 By Application
6.4.2 Disease Diagnosis
6.4.3 Drug Discovery
6.4.4 Education and Training
6.5 By Geography
6.5.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Australia & New Zealand
184.108.40.206 Rest of Asia-Pacific
6.5.4 Middle East & Africa
220.127.116.11 South Africa
18.104.22.168 Rest of the Middle East & Africa
6.5.5 South America
22.214.171.124 Rest of South America
7. Competitive Landscape
7.1 Merger and Acquisition Analysis
7.2 New Product Launches
7.3 Agreements, Collaborations and Partnerships
8. Company Profiles
8.1 Leica Biosystems Nussloch GmbH
8.2 Ventana Medical Systems, Inc.
8.3 Hamamatsu Photonics K.K
8.4 3DHistech Ltd.
8.5 Philips Healthcare
8.6 Apollo Enterprise Imaging Corp.
8.7 XIFIN, Inc.
8.8 Definiens AG
8.9 Visiopharm A/S
8.10 Omnyx LLC
8.11 Corista LLC
9. Future Outlook of the Market
- Leica Biosystems Nussloch Gmbh
- Ventana Medical Systems Inc.
- Hamamatsu Photonics K.K
- 3Dhistech Ltd.
- Philips Healthcare
- Apollo Enterprise Imaging Corp.
- Xifin Inc.
- Definiens Ag
- Visiopharm A/S
- Omnyx Llc
- Corista Llc